Acura Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.26 |
Market Cap |
$5.66 M |
Shares Outstanding |
21.03 M |
Public Float |
7.21 M |
Address |
616 N. North Court Palatine Illinois 60067 United States |
Employees | - |
Website | http://www.acurapharm.com |
Updated | 07/08/2019 |
Acura Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in the research, development and commercialization of products intended to address medication abuse and misuse, utilizing its proprietary aversion and impede technologies. It operates its business through the research, development, and manufacture of innovative abuse deterrent, orally administered pharmaceutical products. The company was founded in 1935 and is headquartered in Palatine, IL. |